Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $96.0050 (2.54%) ($96.0050 - $96.4200) on Wed. May. 4, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.43% (three month average) | RSI | 29 | Latest Price | $96.0050(2.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.7% a day on average for past five trading days. | Weekly Trend | LGND declines -4.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(59%) IWM(58%) IWC(56%) IWN(55%) | Factors Impacting LGND price | LGND will decline at least -1.715% in a week (0% probabilities). VIXM(-23%) UUP(-19%) VXX(-16%) TBT(-6%) UNG(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.715% (StdDev 3.43%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $83.63(-12.89%) | Resistance Level | $100.58 | 5 Day Moving Average | $94.23(1.88%) | 10 Day Moving Average | $95.15(0.9%) | 20 Day Moving Average | $100.58(-4.55%) | To recent high | -23.3% | To recent low | 3.8% | Market Cap | $1.543b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |